Prodia Diagnostic Line Tbk vs SLJ Global Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while SLJ Global Tbk. trades at Rp96 (market cap 606.79B, 6.96M 24h volume). The key difference: SLJ Global Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 6.96M). Which is the better fit depends on your goals.
| PRDL | SULI | |
|---|---|---|
Market Cap | 470.58B | 606.79B |
Volume | 28.43M | 6.96M |
Lot | 284.34K | 69.57K |
Turnover | 7.8B | 655.33M |
Average Price | 274.19 | 94.2 |
Value | 7.8B | 655.33M |
Indicative Equilibrium Price | 270 | 96 |
Indicative Equilibrium Volume | 2.1K | 1.87K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Read more on SULI →